Expertise in
11
conditions

Dr. Andre Babajanians

Rheumatology
Riverside Medical Clinic Inc.
3660 Arlington Ave, 
Riverside, CA 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
11
conditions
Riverside Medical Clinic Inc.
3660 Arlington Ave, 
Riverside, CA 

Overview

Andre Babajanians is a Rheumatologist practicing medicine in Riverside, California.

Dr. Babajanians is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Mixed Connective Tissue Disease, MASS Phenotype, Sjogren Syndrome, and Fibromyalgia.

He is actively involved in clinical research, participating in 4 clinical trials. Dr. Babajanians is currently accepting new patients.

Specialties

Rheumatology

Licenses

Internal Medicine in CA

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Inland Empire Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

Riverside Medical Clinic Inc.
3660 Arlington Ave, Riverside, CA 92506
Other Locations
Riverside Medical Clinic Inc.
6405 Day St, Riverside, CA 92507

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
Enrollment Status: Terminated
Publish Date: November 30, 2023
Intervention Type: Drug, Biological
Study Drugs: Otilimab, Tofacitinib, csDMARDs
Study Phase: Phase 3
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: October 12, 2023
Intervention Type: Drug
Study Drugs: Olokizumab, Methotrexate
Study Phase: Phase 3
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Tumor Necrosis Factor Alpha (TNF-α) Inhibitor Therapy
A Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Tumor Necrosis Factor Alpha (TNF-α) Inhibitor Therapy
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Drug: Olokizumab
Study Phase: Phase 3
View 3 Less Clinical Trials
Similar Doctors
Expertise in
13
conditions
Dr. Daniel E. Furst
Rheumatology
Expertise in
13
conditions
Dr. Daniel E. Furst
Rheumatology
Referral may be required
Before you request

Daniel Furst MD A Professional Corp.

575 E Hardy St Ste 321, 
Inglewood, CA 
 (54.6 miles away)
818-561-9989
Languages Spoken:
English, German
See accepted insurances
Accepting New Patients
Offers Telehealth

Daniel Furst is a Rheumatologist practicing medicine in Inglewood, California. Dr. Furst is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Systemic Sclerosis (SSc), Scleroderma, Rheumatoid Arthritis (RA), and Arthritis. Dr. Furst is currently accepting new patients.

Expertise in
22
conditions
Expertise in
22
conditions
Referral may be required
Before you request

Cedars-Sinai Rheumatology-Los Angeles

8723 Alden Dr Ste 250, 
Los Angeles, CA 
 (56.7 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Daniel Wallace is a Rheumatologist practicing medicine in Los Angeles, California. Dr. Wallace is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Systemic Lupus Erythematosus (SLE), Lupus Nephritis, Sjogren Syndrome, and Rheumatoid Arthritis (RA). Dr. Wallace is currently accepting new patients.

Expertise in
54
conditions
Dr. Samy K. Metyas
Rheumatology
Expertise in
54
conditions
Dr. Samy K. Metyas
Rheumatology
Referral may be required
Before you request

Metyas, Samy, M.D., Inc.

500 W San Bernardino Rd, 
Covina, CA 
 (30.5 miles away)
626-966-1909
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Samy Metyas is a Rheumatologist practicing medicine in Covina, California. Dr. Metyas is highly rated in 54 conditions, according to our data. His clinical expertise encompasses Fibromyalgia, Rheumatoid Arthritis (RA), Osteoporosis, and Postmenopausal Osteoporosis. Dr. Metyas is board certified in American Board Of Internal Medicine. Dr. Metyas is currently accepting new patients.

Frequently Asked Questions about Dr. Andre Babajanians

How do I make an appointment with Dr. Andre Babajanians?

You can book an appointment with Dr. Andre Babajanians by calling their office at 951-782-6225. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Andre Babajanians a top-rated expert for Mixed Connective Tissue Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Andre Babajanians is classified as an Advanced expert for Mixed Connective Tissue Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Andre Babajanians specialize in?

While Dr. Andre Babajanians is a Rheumatology, they have specific expertise in Mixed Connective Tissue Disease, MASS Phenotype, and Sjogren Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Rheumatology.

Does Dr. Andre Babajanians accept my insurance?

Dr. Andre Babajanians accepts most major insurance plans, including Aetna and Alignment Health Plan. We recommend calling the office directly at 951-782-6225 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Babajanians's expertise for a condition
ConditionClose
      View All 11 Advanced Conditions
      View All 38 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile